Reproducible copy number variation patterns among single circulating tumor cells of lung cancer patients

Xiaohui Ni, Minglei Zhuo, Zhe Su, +22

Proceedings of the National Academy of Sciences

Vandetanib plus docetaxel versus docetaxel as second-line treatment for patients with advanced non-small-cell lung cancer (ZODIAC): a double-blind, randomised, phase 3 trial

Roy S. Herbst, Yan Sun, Wilfried Eberhardt, +15

The Lancet Oncology

Second-line TreatmentOncologyMetronomic TherapyDocetaxel Versus DocetaxelClinical Trials +8

Epidermal Growth Factor Receptor Mutations in Plasma DNA Samples Predict Tumor Response in Chinese Patients With Stages IIIB to IV Non–Small-Cell Lung Cancer

Hua Bai, Li Mao, hang Shu Wang, +11

Journal of Clinical Oncology

Influence of Chemotherapy on <i>EGFR</i> Mutation Status Among Patients With Non–Small-Cell Lung Cancer

Hua Bai, Zhijie Wang, Ke‐Neng Chen, +14

Journal of Clinical Oncology

Multiregion Sequencing Reveals the Genetic Heterogeneity and Evolutionary History of Osteosarcoma and Matched Pulmonary Metastases

Di Wang, Xiaohui Niu, Zhijie Wang, +22

Cancer Research

Quantification and Dynamic Monitoring of EGFR T790M in Plasma Cell-Free DNA by Digital PCR for Prognosis of EGFR-TKI Treatment in Advanced NSCLC

Zhijie Wang, Rui Chen, Shuhang Wang, +9

PLoS ONE

Inferring the Evolution and Progression of Small-Cell Lung Cancer by Single-Cell Sequencing of Circulating Tumor Cells

Zhe Su, Zhijie Wang, Xiaohui Ni, +18

Clinical Cancer Research

Potential Clinical Significance of a Plasma-Based <i>KRAS</i> Mutation Analysis in Patients with Advanced Non–Small Cell Lung Cancer

Shuhang Wang, Tongtong An, Jie Wang, +11

Clinical Cancer Research

KIF15 promotes pancreatic cancer proliferation via the MEK–ERK signalling pathway

Jie Wang, Xingjun Guo, Chencheng Xie, +1

British Journal of Cancer

Detection and Clinical Significance of Intratumoral EGFR Mutational Heterogeneity in Chinese Patients with Advanced Non-Small Cell Lung Cancer

Hua Bai, Zhijie Wang, Yuyan Wang, +8

PLoS ONE